Allworth Financial LP Emergent Bio Solutions Inc. Transaction History

Allworth Financial LP

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2023 Jul 18, 2023	BUY	$7.35 - $13.21 $154 - $277	21 New	21 $0
Q4 2022 Jan 13, 2023	BUY	$11.0 - $21.45 $935 - $1,823	85 Added 1214.29%	92 $0
Q3 2022 Oct 18, 2022	BUY	$20.09 - $35.8 $20 - $35	1 Added 16.67%	7 $0
Q2 2022 Jul 13, 2022	BUY	$27.42 - $43.63 $54 - $87	2 Added 50.0%	6 $0
Q1 2022 Apr 22, 2022	SELL	$36.48 - $52.22 $6,967 - $9,974	-191 Reduced 97.95%	4 $0
Q4 2021 Jan 21, 2022	BUY	$33.11 - $55.01 $6,456 - $10,726	195 New	195 $8,000
Q3 2021 Nov 02, 2021	SELL	$50.07 - $66.05 $6,509 - $8,586	-130 Closed	0 $0
Q1 2020 Apr 17, 2020	BUY	$49.34 - $68.76 $6,414 - $8,938	130 New	130 $8,000

159

33.7M

453K

931K

Ticker EBS
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 49,861,500
Market Cap $427M
Description
Emergent BioSolutions Inc., a life sciences company, focuses on the provision of preparedness and response solutions that address accidental, deliberate, and naturally occurring public health threats (PHTs) in the United States. The company's products address PHTs, which include chemical, biological, radiological, nuclear, and explosives; emergi...

Get notified when there are updates to the investment portfolio of Allworth Financial LP, based on Form 13F filings with the SEC.

Stay updated on Allworth Financial LP with notifications on news.